More people surviving cancer in Northern Ireland

February 28, 2012

Despite the rising incidence of cancer in Northern Ireland, the number of people surviving the disease in the country is increasing significantly year on year.

Each year there are between 50-60 men and women who survive the deadly effects of cancer who previously would have died.

The in Northern Ireland for cancers including breast and colorectal are among the best in the UK, and its patients are benefiting from improved treatment outcomes by up to four per cent better than those for England and Wales.

The figures have been revealed as Queen's University Belfast accepted a Diamond Jubilee Queen's Anniversary Prize at Buckingham Palace, in recognition of its leadership of the Northern Ireland Comprehensive Cancer Services (CCS) programme.

The CCS programme has been credited with driving forward the improvements in in Northern Ireland. It is a collaboration led by Queen's University in partnership with the Department of Health and the five Northern Ireland Health Trusts with support from the medical research industry.

The programme has resulted in the reorganisation of cancer services across Northern Ireland, and investment of more than £200 million in infrastructure and personnel for treatment and research by the University and the health service.

The CCS programme was also recently described by the distinguished medical journal, The Oncologist, as 'life-extending research that is emblematic of the way cancer medicine should be conducted in the 21st century.'

Accepting the prize, Professor Patrick Johnston, Dean of the School of Medicine, Dentistry and Biomedical Sciences, said: "Despite the rising incidence rates of cancer, between 1993 and 2009, the number of men dying from cancer has gone down by 1.3 per cent and the number of women by 0.9 per cent. Some of our survivors are currently alive and well a significant number of years after the kind of cancer that not so long ago would have taken them from us.

"Cancer no longer needs to be seen as an inevitable death sentence. In many instances it can now be viewed instead as a chronic disease."

He added: "This award underpins our reputation as a global centre of excellence for cancer care. To receive it is a singular honour, not just for Queen's but for the whole of Northern Ireland and in particular all the fundraisers, the Department of Health, Social Services and Public Safety, the five Northern Ireland Health and Social Care Trusts and our supporters from the national and international medical research industry.

"Our strength lies in a multidisciplinary approach – teams of scientists and clinicians working together across academic and NHS boundaries on behalf of cancer patients and their families."

Queen's Vice Chancellor Professor Sir Peter Gregson said: "Queen's is committed to high quality translational research. We are seeing innovations which are providing life-saving and life-enhancing results, reflecting our drive to become a global force in the fight against cancer."

The pillars of the CCS programme are the Clinical Cancer Centre at Belfast City Hospital, the Centre for Cancer Research and Cell Biology, the Cancer Research Programme at Queen's and the University's Registry which provides vital information about research and outcomes.

Explore further: Cancer risk in Northern Ireland lower than the Republic of Ireland

Related Stories

Cancer risk in Northern Ireland lower than the Republic of Ireland

December 9, 2011
People in Northern Ireland have a lower risk of developing some cancers than those living in the Republic of Ireland, according to the All-Ireland Cancer Atlas - a collaborative publication by the Northern Ireland Cancer ...

Almost half of cancer survivors have ill health in later years

October 11, 2011
Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University ...

Scientists prove regular aspirin intake halves cancer risk

October 28, 2011
Scientists including those from Queen's University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.

Queen's pioneers prostate cancer breakthrough

September 19, 2011
Scientists at Queen's University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.

Recommended for you

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

How CD44s gives brain cancer a survival advantage

July 19, 2017
Understanding the mechanisms that give cancer cells the ability to survive and grow opens the possibility of developing improved treatments to control or cure the disease. In the case of glioblastoma multiforme, the deadliest ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.